Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Global superbug fight 'needs $5b a year'
antibiotics
Rising antibiotic resistance is triggering the emergence of superbugs that can cause life-threatening infections, such as MRSA or drug-resistant tuberculosis.
Scientists call for a co-ordinated response to drug resistant infections
 
A global fund of $5billion a year is needed to tackle drug-resistant infections, according to predictions by a team of international scientists.

Rising antibiotic resistance is triggering the emergence of superbugs that can cause life-threatening infections, such as MRSA or drug-resistant tuberculosis.

Writing in the journal Science, researchers called for a World Bank Trust Fund to co-ordinate the response to this growing public health crisis.

The annual sum of $5b will be required to develop global systems to monitor resistance and establish a framework to address the threat, they added. It could also speed up the development of new vaccines, diagnostics and treatments, in addition to regulatory processes to ensure medicines are used appropriately.

The group also recommended introducing targets to cut the number of resistant infections over the next five years and putting global limits on antibiotic use. In particular, they believe the use of antibiotics to promote the growth of farmed animals should be phased out across the globe.

In addition, improved access to clean water, sanitation and public health infrastructure, will reduce the spread of disease and the overall need for antibiotics, scientists argued.

Professor Mark Woolhouse from the University of Edinburgh, who took part in the research, added: "Drug resistance knows no borders, as we have seen with the spread of superbugs around the world.

"It is crucial that nations come together with appropriate financing and governance to tackle this challenge together."

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.